SymBio Pharmaceuticals News

SymBio Pharmaceuticals: Change report.

Jul 25 14:23

SymBio Pharmaceuticals: Notice regarding confirmation of the details of the issuance of stock acquisition rights (stock options) to be issued to our employees

Apr 19 16:10

SymBio Pharmaceuticals: Notice regarding determination of the details of the issuance of stock acquisition rights (stock options) to be issued to our directors

Apr 19 16:10

SymBio Pharmaceuticals: Notice of completion of payment for new stock issuance (5th allotment) through third-party allotment based on the Comprehensive Stock Issuance Program (“STEP”) establishment agreement

Apr 19 09:00

Synbio Pharmaceuticals: Notice Concerning Exercise Price Adjustments

Apr 3 14:30

Synbio Pharmaceutical: Determination of issuance conditions for new stock issuance (5th allotment) through third party allotment based on a comprehensive stock issuance program establishment agreement and changes in the amount of funds raised through the n

Apr 3 14:30

Synbio Pharmaceuticals: Revised Securities Registration Form (reference method)

Apr 3 14:05

SymBio Pharmaceuticals: Corrected securities registration form (reference method)

Mar 25 12:07

SymBio Pharmaceuticals: Notice regarding issuance of stock acquisition rights (stock options) to our employees

Mar 22 16:45

SymBio Pharmaceuticals: Notice regarding the issuance of stock acquisition rights (stock options) to our directors

Mar 22 16:45

Synbio Pharmaceuticals: Revised Securities Registration Form (reference method)

Mar 22 14:50

SymBio Pharmaceuticals: Notice of completion of payment for new stock issuance (4th allotment) through third-party allotment based on the Comprehensive Stock Issuance Program (“STEP”) establishment agreement

Mar 18 09:00

Synbio Pharmaceuticals: Notice Concerning Exercise Price Adjustments

Feb 29 15:30

Synbio Pharmaceutical: Determination of issuance conditions for new stock issuance (4th allotment) through third-party allotment based on a comprehensive share issuance program establishment agreement and change in the amount of funds raised through the ne

Feb 29 15:30

Synbio Pharmaceuticals: Revised Securities Registration Form (reference method)

Feb 29 15:07

Synbio Pharmaceuticals: Revised Securities Registration Form (reference method)

Feb 29 15:06

Synbio Pharmaceuticals: Revised Securities Registration Form (reference method)

Feb 22 14:57

Synbio Pharmaceuticals: Revised Securities Registration Form (reference method)

Feb 22 14:55

Synbio Pharmaceuticals: Revised Securities Registration Form (reference method)

Feb 8 15:16

Synbio Pharmaceuticals: Revised Securities Registration Form (reference method)

Feb 8 15:14